Journal of Antimicrobial Chemotherapy

Leading articles:

M. A. VIVIANI

Flucytosine—what is its future?
J. Antimicrob. Chemother. 1995 35: 241-244; doi:10.1093/jac/35.2.241 [PDF] [Request Permissions]  

Review:

S. H. Khoo and E. G. L. Wilkins

Controversies in anti-retroviral therapy of adults
J. Antimicrob. Chemother. 1995 35: 245-262; doi:10.1093/jac/35.2.245 [Abstract] [PDF] [Request Permissions]  

Original articles:

M. J. A. M. P. Pavicic, A. J. van Winkelhoff, Y. A. M. Pavicic-Temming, and J. de Graaff

Metronidazole susceptibility factors in Actinobacillus actinomycetemcomitans
J. Antimicrob. Chemother. 1995 35: 263-269; doi:10.1093/jac/35.2.263 [Abstract] [PDF] [Request Permissions]  

Timothy R. Walsh, David J. Payne, Alasdair P. MacGowan, and Peter M. Bennett

A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible ß-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity
J. Antimicrob. Chemother. 1995 35: 271-279; doi:10.1093/jac/35.2.271 [Abstract] [PDF] [Request Permissions]  

F. Danel, L. M. C. Hall, D. Gur, H. E. Akalin, and D. M. Livermore

Transferable production of PER-1 ß-lactamase in Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1995 35: 281-294; doi:10.1093/jac/35.2.281 [Abstract] [PDF] [Request Permissions]  

Oana Ciofu, Birgit Giwercman, Jan Walter-Rasmussen, Tacjana Pressler, Svend Stenvang Pedersen, and Niels Høiby

Antibodies against Pseudomonas aeruginosa chromosomal ß-lactamase in patients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to ß-lactams
J. Antimicrob. Chemother. 1995 35: 295-304; doi:10.1093/jac/35.2.295 [Abstract] [PDF] [Request Permissions]  

P. Mullany, M. Wilks, and S. Tabaqchali

Transfer of macrolide-lincosamide-streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398
J. Antimicrob. Chemother. 1995 35: 305-315; doi:10.1093/jac/35.2.305 [Abstract] [PDF] [Request Permissions]  

Peter J. Cook, Jenny M. Andrews, Richard Wise, David Honeybourne, and Hamesh Moudgil

Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments
J. Antimicrob. Chemother. 1995 35: 317-326; doi:10.1093/jac/35.2.317 [Abstract] [PDF] [Request Permissions]  

Keren Elhanan, Leonard Siplovich, and Raul Raz

Gentamicin once-daily versus thrice-daily in children
J. Antimicrob. Chemother. 1995 35: 327-332; doi:10.1093/jac/35.2.327 [Abstract] [PDF] [Request Permissions]  

Brief reports:

A. P. MacGowan, K. E. Bowker, K. A. Bedford, H. A. Holf, D. S. Reeves, and A. Hedges

The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins
J. Antimicrob. Chemother. 1995 35: 333-337; doi:10.1093/jac/35.2.333 [Abstract] [PDF] [Request Permissions]  

V. Magnusson, Th. Jonsdottir, H. Gudmundsdottir, H. Erlendsdottir, and S. Gudmundsson

The in-vitro effect of temperature on MICs, bactericidal rates and postantibiotic effects in Staphylococcus aureus, Klebsiella Pneumoniae and Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1995 35: 339-343; doi:10.1093/jac/35.2.339 [Abstract] [PDF] [Request Permissions]  

Thomas Bodmer, Gabriela Zürcher, Paul Imboden, and Amalio Telenti

Mutation position and type of substitution in the ß-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis
J. Antimicrob. Chemother. 1995 35: 345-348; doi:10.1093/jac/35.2.345 [Abstract] [PDF] [Request Permissions]  

Correspondence:

F. A. SIRGEL, A. VENTER, and H.-D. HEILMANN

Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex
J. Antimicrob. Chemother. 1995 35: 349-351; doi:10.1093/jac/35.2.349 [PDF] [Request Permissions]  

JORDI REINA, MARIA JESUS ROS, and VICTORIA FERNANDEZ-BACA

Resistance to erythromycin in fluoroquinolone-resistant Campylobacter jejuni strains isolated from human faeces
J. Antimicrob. Chemother. 1995 35: 351-352; doi:10.1093/jac/35.2.351 [PDF] [Request Permissions]  

MARC WYSOCKI, FRANK THOMAS, MICHEL A. WOLFF, YVES PEAN, YVES RAVAUD, and BERNARD HERMAN

Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections
J. Antimicrob. Chemother. 1995 35: 352-354; doi:10.1093/jac/35.2.352 [PDF] [Request Permissions]  

D. LIEBERMAN and F. SCHLAEFFER

Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections
J. Antimicrob. Chemother. 1995 35: 354-357; doi:10.1093/jac/35.2.354 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.